Alex D. Federman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alex D. Federman has a total of 261 co-authors. Here are the top co-authors by number of shared publications:
Michael S. Wolf
Northwestern Univ, Feinberg Sch Med, Dept Med, New York, NY USA
22 shared publicationsJuan P. Wisnivesky
Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY USA
19 shared publicationsMelissa Martynenko
Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
10 shared publicationsEthan A. Halm
Division of General Internal Medicine, University of Texas Southwestern Medical Center
9 shared publicationsHoward Leventhal
Institute for Health and Department of Psychology, Rutgers University, New Brunswick, NJ, USA
8 shared publications- Juan P. Wisnivesky
Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
7 shared publications
Latest Publications
- 9 October 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Artificial Intelligence-Driven Clinical Decision Support for Postoperative Delirium Prevention: A Pragmatic Randomized Controlled Trial
BACKGROUND: Postoperative delirium affects up to 50% of older adults with cognitive impairment, yet preoperative identification of at-risk patients remains limited. Artificial intelligence methods, such as natural language processing, can extract cognitive impairment signals from electronic health records and enable targeted clinical decision support interventions to promote adherence to perioperative best practices and reduce postoperative delirium. We aimed to evaluate the effectiveness of an artificial intelligence-driven non-interruptive clinical decision support intervention in reducing postoperative delirium by promoting adherence to best practices among anesthesia teams caring for surgical patients with cognitive impairment. METHODS: We conducted a pragmatic randomized controlled trial embedded within routine clinical care at The Mount Sinai Hospital in New York City from June 20, 2023, to August 31, 2024, including patients with preoperative cognitive impairment identified immediately before surgery using a validated natural language processing algorithm, Mini-Mental State Examination scores, or diagnostic codes. Patients were randomized to an artificial intelligence-driven non-interruptive clinical decision support intervention within the electronic health record to promote adherence to best practices among anesthesia teams or routine perioperative care. The primary outcome was postoperative delirium, assessed with the 4 A’s Test within seven days postoperatively. Secondary outcomes were adherence to 12 perioperative best practices. We used chi-square tests for primary and secondary outcome analyses. RESULTS: Overall, 7294 patients were identified as having cognitive impairment immediately before surgery and were randomized to the intervention (n = 3624) or control (n = 3670) group. In total, 1255/7294 (17.2%) patients had documented postoperative delirium assessments, of whom 426/1255 (34%) developed this condition. Between intervention and control groups, there were no statistically significant differences in POD incidence (225/641, 35.1% vs 201/614, 32.7%, P = .37) or best practice adherence (all P > .05). CONCLUSIONS: In this pragmatic randomized controlled trial, less than 20% of the sample had documented delirium assessments due to variability in routine POD screening practices, limiting our ability to conclude that artificial intelligence-driven clinical decision support was not effective in preventing postoperative delirium. However, based on our secondary outcome analyses, the intervention did not significantly change best practice adherence. Further work is needed to determine the best way to use these tools effectively.
- 9 October 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Artificial Intelligence-Driven Clinical Decision Support for Postoperative Delirium Prevention: A Pragmatic Randomized Controlled Trial
BACKGROUND: Postoperative delirium affects up to 50% of older adults with cognitive impairment, yet preoperative identification of at-risk patients remains limited. Artificial intelligence methods, such as natural language processing, can extract cognitive impairment signals from electronic health records and enable targeted clinical decision support interventions to promote adherence to perioperative best practices and reduce postoperative delirium. We aimed to evaluate the effectiveness of an artificial intelligence-driven non-interruptive clinical decision support intervention in reducing postoperative delirium by promoting adherence to best practices among anesthesia teams caring for surgical patients with cognitive impairment. METHODS: We conducted a pragmatic randomized controlled trial embedded within routine clinical care at The Mount Sinai Hospital in New York City from June 20, 2023, to August 31, 2024, including patients with preoperative cognitive impairment identified immediately before surgery using a validated natural language processing algorithm, Mini-Mental State Examination scores, or diagnostic codes. Patients were randomized to an artificial intelligence-driven non-interruptive clinical decision support intervention within the electronic health record to promote adherence to best practices among anesthesia teams or routine perioperative care. The primary outcome was postoperative delirium, assessed with the 4 A’s Test within seven days postoperatively. Secondary outcomes were adherence to 12 perioperative best practices. We used chi-square tests for primary and secondary outcome analyses. RESULTS: Overall, 7294 patients were identified as having cognitive impairment immediately before surgery and were randomized to the intervention (n = 3624) or control (n = 3670) group. In total, 1255/7294 (17.2%) patients had documented postoperative delirium assessments, of whom 426/1255 (34%) developed this condition. Between intervention and control groups, there were no statistically significant differences in POD incidence (225/641, 35.1% vs 201/614, 32.7%, P = .37) or best practice adherence (all P > .05). CONCLUSIONS: In this pragmatic randomized controlled trial, less than 20% of the sample had documented delirium assessments due to variability in routine POD screening practices, limiting our ability to conclude that artificial intelligence-driven clinical decision support was not effective in preventing postoperative delirium. However, based on our secondary outcome analyses, the intervention did not significantly change best practice adherence. Further work is needed to determine the best way to use these tools effectively.
- 27 November 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (4) , 848-857
Longitudinal Pathways Between Major Depressive Disorder and Asthma Outcomes in Older Adults
- 27 November 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (4) , 848-857
Longitudinal Pathways Between Major Depressive Disorder and Asthma Outcomes in Older Adults
- 13 December 2024
- Published by Springer Nature in Journal of Behavioral Medicine
- Vol. 48 (2) , 317-330
The relationship between depressive symptoms and coping style on asthma outcomes in older adults
Objective To examine the impact of coping styles in older adults with asthma on the prospective relationship between depressive symptoms and asthma outcomes, and how their perceptions of social support influenced their coping styles. Methods Adults 60 and over with asthma were recruited and interviewed about their experiences of asthma, depression, and other psychosocial factors over three time points (Baseline, 6-month, and 12-month visits). Structural equation models examined the mediating roles of coping styles in the relationship between depressive symptoms (assessed by BDI-II) and asthma outcomes (i.e., asthma control, asthma quality of life, asthma-related distress, asthma-related hospitalizations, and oral corticosteroid use) and the mediating role of perceived social support in the relationship between depressive symptoms and coping style. Results 455 participants were included in this study. Overall, 33.9% of the study population self-identified as Black and 32.8% as Hispanic. Depressive symptoms at baseline predicted less spiritual coping at 6 months (β = − 0.15, p = 0.03), more negative coping at 6 months (β = 0.44, p < .0001), and worse asthma outcomes at 12 months (β = 0.31, p < .0001). None of the coping styles significantly mediated the relationship between depressive symptoms and asthma outcomes. Perceived social support mediated the relationship between depressive symptoms and positive coping, such that more depressive symptoms predicted less perceived social support, which in turn resulted in less positive coping engagement (β = − 0.06, p = 0.03). Conclusions This study demonstrates that in older adults with asthma depressive symptoms impact perceived social support, coping strategy selection (including spiritual coping), and subsequent asthma outcomes.
- 13 December 2024
- Published by Springer Nature in Journal of Behavioral Medicine
- Vol. 48 (2) , 317-330
The relationship between depressive symptoms and coping style on asthma outcomes in older adults
Objective To examine the impact of coping styles in older adults with asthma on the prospective relationship between depressive symptoms and asthma outcomes, and how their perceptions of social support influenced their coping styles. Methods Adults 60 and over with asthma were recruited and interviewed about their experiences of asthma, depression, and other psychosocial factors over three time points (Baseline, 6-month, and 12-month visits). Structural equation models examined the mediating roles of coping styles in the relationship between depressive symptoms (assessed by BDI-II) and asthma outcomes (i.e., asthma control, asthma quality of life, asthma-related distress, asthma-related hospitalizations, and oral corticosteroid use) and the mediating role of perceived social support in the relationship between depressive symptoms and coping style. Results 455 participants were included in this study. Overall, 33.9% of the study population self-identified as Black and 32.8% as Hispanic. Depressive symptoms at baseline predicted less spiritual coping at 6 months (β = − 0.15, p = 0.03), more negative coping at 6 months (β = 0.44, p < .0001), and worse asthma outcomes at 12 months (β = 0.31, p < .0001). None of the coping styles significantly mediated the relationship between depressive symptoms and asthma outcomes. Perceived social support mediated the relationship between depressive symptoms and positive coping, such that more depressive symptoms predicted less perceived social support, which in turn resulted in less positive coping engagement (β = − 0.06, p = 0.03). Conclusions This study demonstrates that in older adults with asthma depressive symptoms impact perceived social support, coping strategy selection (including spiritual coping), and subsequent asthma outcomes.
- Open Access
Social Vulnerability and Biological Aging in New York City: An Electronic Health Records-Based Study
Chronological age is not an accurate predictor of morbidity and mortality risk, as individuals’ aging processes are diverse. Phenotypic age acceleration (PhenoAgeAccel) is a validated biological age measure incorporating chronological age and biomarkers from blood samples commonly used in clinical practice that can better reflect aging-related morbidity and mortality risk. The heterogeneity of age-related decline is not random, as environmental exposures can promote or impede healthy aging. Social Vulnerability Index (SVI) is a composite index accounting for different facets of the social, economic, and demographic environment grouped into four themes: socioeconomic status, household composition and disability, minority status and language, and housing and transportation. We aim to assess the concurrent and combined associations of the four SVI themes on PhenoAgeAccel and the differential effects on disadvantaged groups. We use electronic health records data from 31,913 patients from the Mount Sinai Health System (116,952 person-years) and calculate PhenoAge for years with available laboratory results (2011-2022). PhenoAge is calculated as a weighted linear combination of lab results and PhenoAgeAccel is the differential between PhenoAge and chronological age. A decile increase in the mixture of SVI dimensions was associated with an increase of 0.23 years (95% CI: 0.21, 0.25) in PhenoAgeAccel. The socioeconomic status dimension was the main driver of the association, accounting for 61% of the weight. Interaction models revealed a more substantial detrimental association for women and racial and ethnic minorities with differences in leading SVI themes. These findings suggest that neighborhood-level social vulnerability increases the biological age of its residents, increasing morbidity and mortality risks. Socioeconomic status has the larger detrimental role amongst the different facets of social environment.
Open AccessSocial Vulnerability and Biological Aging in New York City: An Electronic Health Records-Based Study
Chronological age is not an accurate predictor of morbidity and mortality risk, as individuals’ aging processes are diverse. Phenotypic age acceleration (PhenoAgeAccel) is a validated biological age measure incorporating chronological age and biomarkers from blood samples commonly used in clinical practice that can better reflect aging-related morbidity and mortality risk. The heterogeneity of age-related decline is not random, as environmental exposures can promote or impede healthy aging. Social Vulnerability Index (SVI) is a composite index accounting for different facets of the social, economic, and demographic environment grouped into four themes: socioeconomic status, household composition and disability, minority status and language, and housing and transportation. We aim to assess the concurrent and combined associations of the four SVI themes on PhenoAgeAccel and the differential effects on disadvantaged groups. We use electronic health records data from 31,913 patients from the Mount Sinai Health System (116,952 person-years) and calculate PhenoAge for years with available laboratory results (2011-2022). PhenoAge is calculated as a weighted linear combination of lab results and PhenoAgeAccel is the differential between PhenoAge and chronological age. A decile increase in the mixture of SVI dimensions was associated with an increase of 0.23 years (95% CI: 0.21, 0.25) in PhenoAgeAccel. The socioeconomic status dimension was the main driver of the association, accounting for 61% of the weight. Interaction models revealed a more substantial detrimental association for women and racial and ethnic minorities with differences in leading SVI themes. These findings suggest that neighborhood-level social vulnerability increases the biological age of its residents, increasing morbidity and mortality risks. Socioeconomic status has the larger detrimental role amongst the different facets of social environment.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Gerontology and Geriatric Medicine
- Vol. 10
Relationship Between Cognitive Impairment and Depression Among Middle Aged and Older Adults in Primary Care
Objectives: To determine rates of previously undetected cognitive impairment among patients with depression in primary care. Methods: Patients ages 55 and older with no documented history of dementia or mild cognitive impairment were recruited from primary care practices in New York City, NY and Chicago, IL ( n = 855). Cognitive function was assessed with the Montreal Cognitive Assessment (MoCA) and depression with the Patient Health Questionnaire-8. Results: The mean age was 66.8 (8.0) years, 45.3% were male, 32.7% Black, and 29.2% Latinx. Cognitive impairment increased with severity of depression: 22.9% in persons with mild depression, 27.4% in moderate depression and 41.8% in severe depression ( p = .0002). Severe depression was significantly associated with cognitive impairment in multivariable analysis (standardized β = −.11, SE = 0.33, p < .0001). Discussion: Depression was strongly associated with previously undetected cognitive impairment. Primary care clinicians should consider screening, or expand their screening, for both conditions.
- 1 January 2024
- Published by SAGE Publications in Gerontology and Geriatric Medicine
- Vol. 10
Open AccessRelationship Between Cognitive Impairment and Depression Among Middle Aged and Older Adults in Primary Care
Objectives: To determine rates of previously undetected cognitive impairment among patients with depression in primary care. Methods: Patients ages 55 and older with no documented history of dementia or mild cognitive impairment were recruited from primary care practices in New York City, NY and Chicago, IL ( n = 855). Cognitive function was assessed with the Montreal Cognitive Assessment (MoCA) and depression with the Patient Health Questionnaire-8. Results: The mean age was 66.8 (8.0) years, 45.3% were male, 32.7% Black, and 29.2% Latinx. Cognitive impairment increased with severity of depression: 22.9% in persons with mild depression, 27.4% in moderate depression and 41.8% in severe depression ( p = .0002). Severe depression was significantly associated with cognitive impairment in multivariable analysis (standardized β = −.11, SE = 0.33, p < .0001). Discussion: Depression was strongly associated with previously undetected cognitive impairment. Primary care clinicians should consider screening, or expand their screening, for both conditions.
- 1 January 2024
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 11 (1) , 13-25
Feasibility Trial of a Comprehensive, Highly Patient-Centered COPD Self-Management Support Program
Purpose: To test the feasibility of a novel self -management support intervention for people with chronic obstructive pulmonary disease (COPD). Methods: We conducted a feasibility randomized controlled trial involving patients >= 40 years with severe or very severe COPD in New York, New York (n=59). Community health workers screened patients and addressed barriers to COPD self -management. Patients were also offered home -based pulmonary rehabilitation (HBPR) and an antibiotic and steroid rescue pack. Control patients received general COPD education. Clinical outcomes for intervention and control were compared by difference -in -differences (DiD) at baseline and 6 months. The study was not powered for statistically significant differences for any measure. Feasibility measures were collected at 6 months. Results: There were high rates of completion of intervention activities, including 75% of patients undergoing evaluation for and participating in HBPR. Most (92%) intervention patients said the program was very or extremely helpful and 96% said they would participate again. Clinical outcomes generally favored the intervention: COPD assessment test, DiD -1.1 (95% confidence interval [CI] -5.9 to 3.6); 6 -minute walk test distance, DiD 7.4 meters (95% CI -45.1 to 59.8); self -reported hospitalizations, DiD -9.8% (95% CI -42.3% to 22.8%); medication adherence, DiD 7.7% (-29.6%, 45.0%), and Physical Activity Adult Questionnaire, DiD 86 (95% CI -283 to 455). Intervention patients reported more emergency department visits, DiD 10.6% (95% CI 17.7% to 38.8%). Conclusions: A highly patient -centered, self -management support intervention for people with COPD was well received by patients and associated with potential improvements in clinical and self -management outcomes. A fully powered study of the intervention is warranted.
- 1 January 2024
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 11 (1) , 13-25
Feasibility Trial of a Comprehensive, Highly Patient-Centered COPD Self-Management Support Program
Purpose: To test the feasibility of a novel self -management support intervention for people with chronic obstructive pulmonary disease (COPD). Methods: We conducted a feasibility randomized controlled trial involving patients >= 40 years with severe or very severe COPD in New York, New York (n=59). Community health workers screened patients and addressed barriers to COPD self -management. Patients were also offered home -based pulmonary rehabilitation (HBPR) and an antibiotic and steroid rescue pack. Control patients received general COPD education. Clinical outcomes for intervention and control were compared by difference -in -differences (DiD) at baseline and 6 months. The study was not powered for statistically significant differences for any measure. Feasibility measures were collected at 6 months. Results: There were high rates of completion of intervention activities, including 75% of patients undergoing evaluation for and participating in HBPR. Most (92%) intervention patients said the program was very or extremely helpful and 96% said they would participate again. Clinical outcomes generally favored the intervention: COPD assessment test, DiD -1.1 (95% confidence interval [CI] -5.9 to 3.6); 6 -minute walk test distance, DiD 7.4 meters (95% CI -45.1 to 59.8); self -reported hospitalizations, DiD -9.8% (95% CI -42.3% to 22.8%); medication adherence, DiD 7.7% (-29.6%, 45.0%), and Physical Activity Adult Questionnaire, DiD 86 (95% CI -283 to 455). Intervention patients reported more emergency department visits, DiD 10.6% (95% CI 17.7% to 38.8%). Conclusions: A highly patient -centered, self -management support intervention for people with COPD was well received by patients and associated with potential improvements in clinical and self -management outcomes. A fully powered study of the intervention is warranted.
- Open Access
An Effective Automated Algorithm to Isolate Patient Speech from Conversations with Clinicians
A growing number of algorithms are being developed to automatically identify disorders or disease biomarkers from digitally recorded audio of patient speech. An important step in these analyses is to identify and isolate the patient’s speech from that of other speakers or noise that are captured in a recording. However, current algorithms, such as diarization, only label the identified speech segments in terms of non-specific speakers, and do not identify the specific speaker of each segment, e.g., clinician and patient. In this paper, we present a novel algorithm that not only performs diarization on clinical audio, but also identifies the patient among the speakers in the recording and returns an audio file containing only the patient’s speech. Our algorithm first uses pretrained diarization algorithms to separate the input audio into different tracks according to nonspecific speaker labels. Next, in a novel step not conducted in other diarization tools, the algorithm uses the average loudness (quantified as power) of each audio track to identify the patient, and return the audio track containing only their speech. Using a practical expert-based evaluation methodology and a large dataset of clinical audio recordings, we found that the best implementation of our algorithm achieved near-perfect accuracy on two validation sets. Thus, our algorithm can be used for effectively identifying and isolating patient speech, which can be used in downstream expert and/or data-driven analyses.
Open AccessAn Effective Automated Algorithm to Isolate Patient Speech from Conversations with Clinicians
A growing number of algorithms are being developed to automatically identify disorders or disease biomarkers from digitally recorded audio of patient speech. An important step in these analyses is to identify and isolate the patient’s speech from that of other speakers or noise that are captured in a recording. However, current algorithms, such as diarization, only label the identified speech segments in terms of non-specific speakers, and do not identify the specific speaker of each segment, e.g., clinician and patient. In this paper, we present a novel algorithm that not only performs diarization on clinical audio, but also identifies the patient among the speakers in the recording and returns an audio file containing only the patient’s speech. Our algorithm first uses pretrained diarization algorithms to separate the input audio into different tracks according to nonspecific speaker labels. Next, in a novel step not conducted in other diarization tools, the algorithm uses the average loudness (quantified as power) of each audio track to identify the patient, and return the audio track containing only their speech. Using a practical expert-based evaluation methodology and a large dataset of clinical audio recordings, we found that the best implementation of our algorithm achieved near-perfect accuracy on two validation sets. Thus, our algorithm can be used for effectively identifying and isolating patient speech, which can be used in downstream expert and/or data-driven analyses.
- 20 August 2022
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 71 (2) , 443-454
Outcomes of home‐based primary care for homebound older adults: A randomized clinical trial
Background: Homebound older adults are medically complex and often have difficulty accessing outpatient medical care. Home‐based primary care (HBPC) may improve care and outcomes for this population but data from randomized trials of HBPC in the United States are limited. Methods: We conducted a randomized controlled trial of HBPC versus office‐based primary care for adults ages ≥65 years who reported ≥1 hospitalization in the prior 12 months and met the Medicare definition of homebound. HBPC was provided by teams consisting of a physician, nurse practitioner, nurse, and social worker. Data were collected at baseline, 6‐ and 12‐months. Outcomes were quality of life, symptoms, satisfaction with care, hospitalizations, and emergency department (ED) visits. Recruitment was terminated early because more deaths were observed for intervention patients. Results: The study enrolled 229 patients, 65.4% of planned recruitment. The mean age was 82 (9.0) years and 72.3% had dementia. Of those assigned to HBPC, 34.2% never received it. Intervention patients had greater satisfaction with care than controls (2.26, 95% CI 1.46–3.06, p < 0.0001; effect size 0.74) and lower hospitalization rates (−17.9%, 95% CI −31.0% to −1.0%; p = 0.001; number needed to treat 6, 95% CI 3–100). There were no significant differences in quality of life (1.25, 95% CI −0.39–2.89, p = 0.13), symptom burden (−1.92, 95% CI −5.22–1.37, p = 0.25) or ED visits (1.2%, 95% CI −10.5%–12.4%; p = 0.87). There were 24 (21.1%) deaths among intervention patients and 12 (10.7%) among controls ( p < 0.0001). Conclusion: HBPC was associated with greater satisfaction with care and lower hospitalization rates but also more deaths compared to office‐based primary care. Additional research is needed to understand the nature of the higher death rate for HBPC patients, as well as to determine the effects of HBPC on quality of life and symptom burden given the trial's early termination.
- 20 August 2022
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 71 (2) , 443-454
Outcomes of home‐based primary care for homebound older adults: A randomized clinical trial
Background: Homebound older adults are medically complex and often have difficulty accessing outpatient medical care. Home‐based primary care (HBPC) may improve care and outcomes for this population but data from randomized trials of HBPC in the United States are limited. Methods: We conducted a randomized controlled trial of HBPC versus office‐based primary care for adults ages ≥65 years who reported ≥1 hospitalization in the prior 12 months and met the Medicare definition of homebound. HBPC was provided by teams consisting of a physician, nurse practitioner, nurse, and social worker. Data were collected at baseline, 6‐ and 12‐months. Outcomes were quality of life, symptoms, satisfaction with care, hospitalizations, and emergency department (ED) visits. Recruitment was terminated early because more deaths were observed for intervention patients. Results: The study enrolled 229 patients, 65.4% of planned recruitment. The mean age was 82 (9.0) years and 72.3% had dementia. Of those assigned to HBPC, 34.2% never received it. Intervention patients had greater satisfaction with care than controls (2.26, 95% CI 1.46–3.06, p < 0.0001; effect size 0.74) and lower hospitalization rates (−17.9%, 95% CI −31.0% to −1.0%; p = 0.001; number needed to treat 6, 95% CI 3–100). There were no significant differences in quality of life (1.25, 95% CI −0.39–2.89, p = 0.13), symptom burden (−1.92, 95% CI −5.22–1.37, p = 0.25) or ED visits (1.2%, 95% CI −10.5%–12.4%; p = 0.87). There were 24 (21.1%) deaths among intervention patients and 12 (10.7%) among controls ( p < 0.0001). Conclusion: HBPC was associated with greater satisfaction with care and lower hospitalization rates but also more deaths compared to office‐based primary care. Additional research is needed to understand the nature of the higher death rate for HBPC patients, as well as to determine the effects of HBPC on quality of life and symptom burden given the trial's early termination.
- 21 September 2021
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 110, 106570
Protocol for a feasibility randomized trial of self-management support for people with chronic obstructive pulmonary disease using lay health coaches
- 21 September 2021
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 110, 106570
Protocol for a feasibility randomized trial of self-management support for people with chronic obstructive pulmonary disease using lay health coaches